| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.49 | 0.003 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.39 | 0.004 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |